Resultado de búsqueda
Feng Zhang (China, 1981) es un neurocientífico especializado en optogenética y biología de síntesis, que investiga sobre herramientas de edición del ADN y su aplicación al tratamiento futuro de enfermedades psiquiátricas.
Feng Zhang. HHMI / Massachusetts Institute of Technology / Broad Institute of MIT and Harvard. Verified email at mit.edu - Homepage. neuroscience microbiology optogenetics genome engineering. ... ES Boyden, F Zhang, E Bamberg, G Nagel, K Deisseroth. Nature neuroscience 8 (9), 1263-1268, 2005. 5778: 2005:
Feng Zhang is a molecular biologist and a core institute member of the Broad Institute, where he develops and applies genome editing tools for studying the brain and human diseases. He is also an investigator at the McGovern Institute, the James and Patricia Poitras Professor of Neuroscience at MIT, and a professor at MIT.
Feng Zhang (Chinese: 张锋; pinyin: Zhāng Fēng; born October 22, 1981) is a Chinese–American biochemist. Zhang currently holds the James and Patricia Poitras Professorship in Neuroscience at the McGovern Institute for Brain Research and in the departments of Brain and Cognitive Sciences and Biological Engineering at the ...
Dr. Zhang is a molecular biologist focused on improving human health. He played an integral role in the development of two revolutionary technologies, optogenetics and CRISPR-Cas systems, including pioneering the use of Cas9 for genome editing and discovering CRISPR-Cas12 and Cas13 systems and developing them for therapeutic and diagnostic ...
Feng Zhang is a professor and investigator at MIT and the Broad Institute, where he develops CRISPR tools for genome editing and disease research. He also studies brain disorders such as autism and Alzheimer's, and is a founder of several biotech companies.
28 de jun. de 2023 · Feng Zhang and his team at MIT and the Broad Institute have uncovered a RNA-guided DNA-cutting enzyme in eukaryotes, Fanzor, that can edit the human genome. Fanzor is based on a protein that evolved from bacteria and has potential applications as a new genome editing tool.
